Targeting FUS-ALS aggregation with Proteasome Inhibitors
Amal Younis, Kanar Yassen, Kinneret Rozales…·Reut Shalgi
This study shows proteasome inhibitors reduce FUS aggregation in ALS models through HSF1-dependent transcriptional mechanisms, suggesting a potential therapeutic strategy for ALS-FUS.